Featured post
SCS research and awards news
For all our research and awards news, please visit our news page.
Monday 19 March 2018
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma
George Grigoriadis
et al.
published in the
British Journal of Haematology.
Read article
here
.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment